| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.03 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.03 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.32 | 0.03 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |